8Danan G,Benichou C.Causality assessment of adverse reactionsto drugs-I.A novel method based on the conclusions of internation-al consensus meetings:application to drug-induced liver injuries[J].J Clin Epidemiol,1993,46(11):1323-30.
9Hunt C M,Papay J I,Edwards R I,et al.Monitoring liver safetyin drug development:the GSK experience[J].Regul ToxicolPharmacol,2007,49(2):90-100.
10Larrey D.Epidemiology and individual susceptibility to adversedrug reactions affecting the liver[J].Semin Liver Dis,2002,22(2):145-55.
